Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Ark Genomic Revolution Multi-Sector ETF (NY: ARKG)
46.34 USD  +1.05 (+2.32%)
Official Closing Price  /  Updated: 8:00 PM EDT, May 29, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Ark Genomic Revolution Multi-Sector ETF
Sector
Exchange Traded NY
Net Assets 148.53M
Inception Date
Related Funds
Quote
Price 46.34
Volume 478,500
Last Trade May 29, 8:00pm
Change (%)
+1.05 (2.32%)
Prev. Close 45.29
YTD %
+38.95%
Dividend Yield N/A
Performance
YTD
+12.99 (38.95%)
1 Month
+4.53 (10.83%)
3 Month
+11.95 (34.75%)
6 Month
+11.42 (32.70%)
1 Year
+16.30 (54.26%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
5 ETFs Up More Than 20% in Three Months
Here are five ETFs from different corners of the broad market that have outperformed and gained at least 20% over the past three months. Read More
from Blogs - TalkMarkets
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain
Given rising spending on drugs and healthcare all over the world, investors should tap the opportune moment by investing in the biotech sector. Read More
from Blogs - TalkMarkets
Top News
More News
This Genomics ETF is Performing Like a Freak of Nature
The ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG) fund may focus on biotechnological advances, but it’s been delivering freak of nature-like returns as of late. With ARKG up over 40% YTD... Read More
from ETF Trends
3 Genomics ETFs Worth Jumping For
The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced exchange-traded funds targeting the group are... Read More
from Blogs - TalkMarkets
3 Genomics ETFs Worth Jumping For
The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, ... Read More
from Benzinga
Profit From The Genomics Market Momentum With These ETFs
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that... Read More
from Blogs - TalkMarkets
Power of Precision Medicine Could be Fueled Here
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is establishing a reputation for being one of the best-performing healthcare ETFs, a legacy forged over its multi-year lifespan, not just a few... Read More
from ETF Trends
Power of Precision Medicine May Be Fueled Here
The ARK Genomic Revolution Multi-Sector Fund ( ARKG ) is establishing a reputation for being one of the best-performing healthcare ETFs, a legacy forged over its multi-year lifespan, not just a few... Read More
from ETFdb
Healthcare, Meet Momentum
The rush is on to develop vaccines and therapies. Read More
from Blogs - TalkMarkets
Genomics ETF Setting Up Nicely for Long-Term
Genomics is evolving and that evolution confirms an a strong underlying investment thesis, one accessible via the ARK Genomic Revolution Multi-Sector Fund ( ARKG ). Already one of the best-performing... Read More
from ETFdb
Dave Nadig Talks Biotech ETFs to Watch On Yahoo Finance
Kicking off the week, ETF Trends’ CIO and Director of Research, Dave Nadig, and Yahoo Finance’s Seana Smith discuss the biotech industry outlook as the push for Coronavirus treatments continue.... Read More
from ETF Trends
Genomics ETF Setting Up Nicely for the Long-Term
Genomics is evolving and that evolution confirms an a strong underlying investment thesis, one accessible via the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Already one of the... Read More
from ETF Trends
Genomic Stocks Are in the First Inning of a Multi-Year Megatrend
By Justin Spittler It’s easily the most overlooked megatrend I’ve ever written about. Folks ignore this opportunity because it’s tough to wrap your head around. But it’s absolutely worth understanding.... Read More
from ETF Trends
Why ETF Investors Should Consider Allocating to Innovation
Exchange traded fund investors should start thinking of “innovation” as an asset class worthy of its own allocation in a diversified global portfolio. In the recent webcast, Making the Case for... Read More
from ETF Trends
Making the Case for Innovation: Rethinking Traditional Asset Allocation
Innovative ideas and technologies should drive global growth, now more than ever. Investors need to be ready to capitalize on rapidly changing market dynamics and breakthrough innovations. In the... Read More
from ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.